EP0957772A2 - Dispositif et procede pour preparer et appliquer une composition pour proteger les blessures - Google Patents

Dispositif et procede pour preparer et appliquer une composition pour proteger les blessures

Info

Publication number
EP0957772A2
EP0957772A2 EP96931360A EP96931360A EP0957772A2 EP 0957772 A2 EP0957772 A2 EP 0957772A2 EP 96931360 A EP96931360 A EP 96931360A EP 96931360 A EP96931360 A EP 96931360A EP 0957772 A2 EP0957772 A2 EP 0957772A2
Authority
EP
European Patent Office
Prior art keywords
fluid
manifold
gas
inlet
channel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP96931360A
Other languages
German (de)
English (en)
Inventor
Andrew G. Hood, Iii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Interpore Orthopaedics Inc
Original Assignee
Quantic Biomedical Partners
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quantic Biomedical Partners filed Critical Quantic Biomedical Partners
Publication of EP0957772A2 publication Critical patent/EP0957772A2/fr
Ceased legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05C—APPARATUS FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05C17/00—Hand tools or apparatus using hand held tools, for applying liquids or other fluent materials to, for spreading applied liquids or other fluent materials on, or for partially removing applied liquids or other fluent materials from, surfaces
    • B05C17/005—Hand tools or apparatus using hand held tools, for applying liquids or other fluent materials to, for spreading applied liquids or other fluent materials on, or for partially removing applied liquids or other fluent materials from, surfaces for discharging material from a reservoir or container located in or on the hand tool through an outlet orifice by pressure without using surface contacting members like pads or brushes
    • B05C17/00553—Hand tools or apparatus using hand held tools, for applying liquids or other fluent materials to, for spreading applied liquids or other fluent materials on, or for partially removing applied liquids or other fluent materials from, surfaces for discharging material from a reservoir or container located in or on the hand tool through an outlet orifice by pressure without using surface contacting members like pads or brushes with means allowing the stock of material to consist of at least two different components
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00491—Surgical glue applicators
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
    • B01F23/40—Mixing liquids with liquids; Emulsifying
    • B01F23/45—Mixing liquids with liquids; Emulsifying using flow mixing
    • B01F23/454—Mixing liquids with liquids; Emulsifying using flow mixing by injecting a mixture of liquid and gas
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
    • B01F25/20—Jet mixers, i.e. mixers using high-speed fluid streams
    • B01F25/25—Mixing by jets impinging against collision plates
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F33/00—Other mixers; Mixing plants; Combinations of mixers
    • B01F33/50—Movable or transportable mixing devices or plants
    • B01F33/501—Movable mixing devices, i.e. readily shifted or displaced from one place to another, e.g. portable during use
    • B01F33/5011—Movable mixing devices, i.e. readily shifted or displaced from one place to another, e.g. portable during use portable during use, e.g. hand-held
    • B01F33/50112—Movable mixing devices, i.e. readily shifted or displaced from one place to another, e.g. portable during use portable during use, e.g. hand-held of the syringe or cartridge type
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F35/00—Accessories for mixers; Auxiliary operations or auxiliary devices; Parts or details of general application
    • B01F35/10—Maintenance of mixers
    • B01F35/13—Maintenance of mixers using one or more of the components of the mixture to wash-out the mixer
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F35/00—Accessories for mixers; Auxiliary operations or auxiliary devices; Parts or details of general application
    • B01F35/10—Maintenance of mixers
    • B01F35/145—Washing or cleaning mixers not provided for in other groups in this subclass; Inhibiting build-up of material on machine parts using other means
    • B01F35/1452—Washing or cleaning mixers not provided for in other groups in this subclass; Inhibiting build-up of material on machine parts using other means using fluids
    • B01F35/1453—Washing or cleaning mixers not provided for in other groups in this subclass; Inhibiting build-up of material on machine parts using other means using fluids by means of jets of fluid, e.g. air
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F35/00—Accessories for mixers; Auxiliary operations or auxiliary devices; Parts or details of general application
    • B01F35/50—Mixing receptacles
    • B01F35/52—Receptacles with two or more compartments
    • B01F35/522—Receptacles with two or more compartments comprising compartments keeping the materials to be mixed separated until the mixing is initiated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00491—Surgical glue applicators
    • A61B2017/00495—Surgical glue applicators for two-component glue
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05C—APPARATUS FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05C17/00—Hand tools or apparatus using hand held tools, for applying liquids or other fluent materials to, for spreading applied liquids or other fluent materials on, or for partially removing applied liquids or other fluent materials from, surfaces
    • B05C17/005—Hand tools or apparatus using hand held tools, for applying liquids or other fluent materials to, for spreading applied liquids or other fluent materials on, or for partially removing applied liquids or other fluent materials from, surfaces for discharging material from a reservoir or container located in or on the hand tool through an outlet orifice by pressure without using surface contacting members like pads or brushes
    • B05C17/01—Hand tools or apparatus using hand held tools, for applying liquids or other fluent materials to, for spreading applied liquids or other fluent materials on, or for partially removing applied liquids or other fluent materials from, surfaces for discharging material from a reservoir or container located in or on the hand tool through an outlet orifice by pressure without using surface contacting members like pads or brushes with manually mechanically or electrically actuated piston or the like

Definitions

  • the present invention relates to a device and method for mixing a plurality of fluids and dispensing the resultant mixture, wherein a gas is used to force the mixture out of the device.
  • the present invention relates to a device and method for preparing and dispensing a wound sealant.
  • a number of applications require the mixing of a plurality of fluids immediately before use of the mixture.
  • fluids include the components of "fibrin glue" wound sealants, gel components for use in electrophoresis, and the components of epoxy cement.
  • the components must be combined in appropriate amounts, thoroughly mixed to form a mixture, and dispensed before increased viscosity impairs mixture flow.
  • Wound sealants are used in the repair of damaged tissues and vessels.
  • wound sealants are designed to prevent persistent fluid loss from or into a wound, which can increase patient discomfort and morbidity, prolong recovery, and compromise or prevent an otherwise successful outcome.
  • Fibrin glue is formed by using a fibrinogen activator, such as thrombin, to cleave fibrinogen to fibrin, followed by formation of a coagulum by fibrin-fibrin crosslinking. Fibrin molecules also form crosslinks with collagen, a principle constituent of most tissues. These fibrin- collagen crosslinks promote adherence of the fibrin clot to the tissue to be sealed.
  • a fibrinogen activator such as thrombin
  • fibrin glues can be prepared from a patient's own blood, thus eliminating the problems of disease transmission and immunological complications associated with the use of donor materials.
  • the rate of coagulum formation can be adjusted to suit the needs of a particular application by adjusting the concentration of fibrinogen activator in the mixture.
  • fibrin glues are predominantly physiologic in origin, and therefore normal fibrinolytic processes remove the coagulum, typically, within two to three weeks, leaving minimal scarring. If desirable, coagulum breakdown can be slowed by the addition of antifibrinolytics such as e-amino caproic acid, tranexamic acid, or aprotinin. Finally, other chemical agents, such as antibiotics or anticancer drugs, can be added to the fibrinogen and or fibrinogen activator solutions before mixing to provide sustained release of the agent at a wound site or selected site of action. While the benefits of fibrin glue wound sealants are clear, the preparation and use of fibrin glues is complicated by several problems. For example, thorough mixing is required to form a strong adhesive. However, a limited time period is available for mixing, given that coagulation begins immediately upon contact of the fibrinogen solution with the fibrinogen activator solution.
  • fibrin glues are typically applied using a syringe-like applicator, in which the coagulating mixture must flow through a relatively small aperture. Any interruption in the flow of the mixture, which is often necessary during wound sealing, can result in formation of a coagulum that plugs the aperture. When this happens, treatment can be continued only by replacing the applicator or, in some devices, clogged applicator parts.
  • 4,359,049 has a spraying head, rather than a mixing needle, wherein a spray is produced by sterile gas supplied at the outlet of each of the fluid channels.
  • a variation of this device described in U.S. Patent No. 4,631,055 (issued December 23, 1986 to Redl et al.) , has a connecting head adapted to connect either to a mixing needle or a multi-lumen catheter.
  • the connecting head includes a third fluid channel for a gas.
  • Each of the channels is designed connect to a separate lumen of the catheter. Thus, fluids in the three channels come together at the inlet of the mixing needle or at the outlet of the catheter.
  • This design was intended to allow the application of fibrin glue in the form of a liquid or fine spray by varying the relative flow rates of fibrinogen, fibrinogen activator, and gas.
  • a sputtering effect rather than a fine, even spray, is observed.
  • the catheter embodiment suffers from the disadvantage that mixing occurs in an uncontrolled manner after the fluid streams exit the catheter.
  • the present invention comprises a device having a manifold for mixing a plurality of fluids and applying the resultant mixture.
  • the manifold includes an inlet end having first and second inlets and an outlet end opposite the inlet end having first and second outlets.
  • First and second fluid channels extend from the first and second inlets to the first and second outlets.
  • a gas channel extends from a third inlet and terminates at and is continuous with the first fluid channel.
  • a one-way valve is positioned in the line providing gas.
  • the one-way valve is attached to a gas inlet fitting in the manifold.
  • the device is used to mix and dispense a wound sealant.
  • the wound sealant preparation and application device of the present invention combines appropriate amounts of a plurality of fluid components, provides vigorous mixing action, and rapidly dispenses the resultant mixture.
  • the gas channel provides a purge feature that expels any mixture remaining in the device to ensure that the device does not become clogged during interruptions in use.
  • FIG. 1 is longitudinal cross-section of a device according the present invention.
  • FIGs. 2A and 2B show portions of another embodiment of the device of FIG. 1.
  • FIG. 3 illustrates the positioning of a plurality of fluid channels with respect to a mixing chamber according to the principles of the present invention.
  • FIG. 4 shows a view of an outlet end of a manifold of the device of FIG. 1 that illustrates the relative positions of a plurality of fluid channel outlets.
  • FIG. 1 shows a preparation and application device 100 (hereinafter device 100) useful for dispensing a mixture of a plurality of fluids, wherein the plurality of fluids is mixed to form a viscous mixture immediately before use.
  • the viscous mixture is exemplified herein by a fibrin glue wound sealant.
  • device 100 includes a plurality of fluid delivery systems, syringes 102, 104 removably connected to a manifold 110 having a plurality of separate fluid channels 112, 114, i.e., one fluid channel for each fluid delivery system.
  • Each fluid delivery system is coupled to a fluid channel which conducts fluid from the fluid delivery system to a mixing chamber 116 at a predetermined volume flow rate.
  • mixing chamber 116 Upon mixing in mixing chamber 116, the plurality of fluids form the desired viscous mixture.
  • the relationship of the plurality of fluid channels 112, 114 and of mixing chamber 116 ensures that vigorous mixing occurs in mixing chamber 116.
  • device 100 includes a purge system that ejects any residual mixture during interruptions in use of device 100, thereby preventing the residual mixture from clogging device 100.
  • the present invention also provides an application system for use in device 100 as well as a method for preparing and dispensing a mixture of a plurality of fluids.
  • device 100 includes syringes 102, 104, which are the fluid delivery systems in this embodiment and eject fluid through syringe outlets 102a, 104a, respectively.
  • the sizes of syringes 102, 104 and corresponding syringe outlets 102a and 104a may be the same or different.
  • syringes 102, 104 have identical lengths, but have different cross-sectional areas at lines 1-1.
  • syringes 102, 104 When device 100 is used to prepare and apply fibrin glues, syringes 102, 104 generally have a cross-sectional area ratio of about 10:1 or greater.
  • outlets 102a, 104a of syringes 102, 104 also have proportionately different cross-sectional areas at lines 2-2.
  • syringes 102, 104 have a cross-sectional area ratio at line 1-1 of 10:1
  • syringe outlets 102a, 104a also have a cross-sectional area ratio at line 2-2 of 10:1.
  • fluid delivery systems are syringes in FIG. 1, those skilled in the art recognize that syringes 102 and 104 can be replaced with any system capable of ejecting a predetermined amount of fluid.
  • the fluid delivery system can include tubing connected to a pressurized fluid source.
  • device 100 can include a common activation mechanism for the fluid delivery systems. Suitable common activation mechanisms do not differ from those known in the art.
  • suitable common activation mechanisms for syringes 102, 104 include a part linking plungers 106, 108, such as an adaptor that fits over the ends 106a, 108a of plungers 106, 108 or a nonflexible bridge linking the plunger stems 106b, 108b of plungers 106, 108. If depression of the plungers is automated, device 100 can include a common timing control unit that activates plungers 106, 108 substantially simultaneously.
  • the common activation means can include manual push-button type valves positioned in the flowpath between the pressurized fluid sources and the fluid system outlets, wherein the valves are operably linked so that pushing a button activates flow from each of the pressurized fluid sources substantially simultaneously.
  • the common activation means can include a common timing control unit that activates substantially simultaneous flow from the pressurized fluid sources.
  • Syringes 102, 104 are removably connected to fluid inlet fittings 118, 120 positioned on a manifold inlet end 110a of manifold 110 at fluid channel inlets 112a, 114a.
  • Fluid inlet fittings 118, 120 couple syringes 102, 104, respectively, to fluid channels 112, 114, respectively.
  • Fluid inlet fittings 118, 120 can be any type of joining piece that forms a fluid-tight seal between manifold 110 and syringes 102, 104 and provides fluid communication between syringes 102, 104 and fluid channels 112, 114, respectively.
  • Fluid inlet fittings 118, 120 can be extensions of manifold 110 or separate pieces mounted on manifold 110.
  • the corresponding inlet fitting can include a mechanism that forms a positive connection with the syringe, such as a luer taper that fits into a luer taper on the syringe tip.
  • the mechanism can be interlocking, such as, for example, luer lock ears that engage a luer fitting on the syringe.
  • Manifold 110 also has manifold outlet end 110b opposite manifold inlet end 110a, with fluid channel outlets 112b, 114b of fluid channels 112, 114 located in manifold outlet end 110b. Fluid channels 112, 114 extend from fluid channel inlets 112a, 114a, respectively, to fluid channel outlets 112b, 114b, respectively.
  • the size and shape of manifold 110 is dictated by the particular application. The embodiment shown in FIG. 1 is suitable for use in dispensing a fibrin glue. Therefore, device 100 is small enough to facilitate one-handed operation, and manifold inlet end 110a is wider than manifold outlet end 110b. In particular, manifold inlet end 110a is sufficiently wide to facilitate connection of a plurality of syringes.
  • the syringes can be eccentric syringes, facilitating locating fluid inlet fittings 118, 120 closer together than with regular syringes.
  • Manifold outlet end 110b is suitably sized to accommodate a delivery spout 124 containing mixing chamber 116, which is described more fully hereinafter.
  • Manifold 110 additionally includes gas channel 130, with gas channel inlet 130a and gas channel outlet 130b.
  • gas channel inlet r.30a is located on manifold inlet end 110a.
  • the location of gas channel inlet 130 is not critical and can vary with the design of manifold 110.
  • gas channel inlet 130a can be located at any convenient position on manifold 110 that does not interfere with connection of syringes 102, 104 to manifold 110 and facilitates suitable positioning of gas channel 130.
  • Gas channel 130 terminates at and is continuous with fluid channel 112 at outlet 130b, which is closer to fluid channel outlet 112b than to fluid channel inlet 112a.
  • gas channel outlet 130b is sufficiently close to fluid channel outlet 112b so that fluid channel 112 does not become clogged by contact with the mixture of fluids in mixing chamber 116, as described in more detail hereinafter.
  • gas channel outlet 130b is sufficiently close to fluid channel outlet 112a to facilitate intermittent operation of device 100.
  • gas exiting gas channel outlet 130b fills a portion of channel 112 between gas channel outlet 130b and mixing chamber 116.
  • This volume is preferably small, to avoid substantial dilution of fluid in fluid channel 112 with gas, which could otherwise alter the ratio of fluid mixture components when operation begins again.
  • gas channel outlet 13Ob is located so that not more than about one-tenth to about two-tenths of the volume of fluid channel 112 is contained in the portion of fluid channel 112 between gas channel outlet 130b and mixing chamber 116.
  • Gas inlet fitting 132 positioned on manifold 110 at gas channel inlet 130a and one-way valve 134 positioned in gas inlet fitting 132.
  • Gas inlet fitting 132 can be any type of joining piece that forms a gas-tight seal between manifold 110 and a pressurized fluid source.
  • gas inlet fitting 132 can be separate from or part of the manifold.
  • One-way valve 134 is positioned to communicate with gas channel 130 so as to provide gas flow from gas channel inlet 130a to gas channel outlet 130b only.
  • One-way valve 132 can be connected to gas inlet fitting 132, as shown in FIG. 1, or positioned at any point along the route of the gas from its source to gas channel 130.
  • One-way valve 134 includes a mechanism at one way valve inlet 134a to provide gas-tight coupling to a pressurized gas source, as described more fully hereinafter.
  • Delivery spout 124 is positioned on manifold outlet end 110b.
  • delivery spout 124 contains an annulus 126 and a catheter 128.
  • Annulus 126 has an inner surface that serves as a wall 125 of mixing chamber 116.
  • Delivery spout 124 can be formed as a unitary part of manifold 110 or can be removably connected to manifold 110.
  • catheter 128 can be part of or removably connected to delivery spout 124. Catheters are readily connected to devices using various types of connectors.
  • the delivery spout can form a luer taper for attachment of a catheter hub.
  • catheter 128 can be replaced with a spray jet-type nozzle.
  • FIG. 2A An embodiment of device 100 wherein manifold 110 is designed for removably connecting delivery spout 124 is illustrated in FIG. 2A.
  • manifold outlet end 110b is a tapered region containing fluid channel outlets 112b, 114b that is encircled by spout fitting 136.
  • manifold 110 is illustrated as tapered in this embodiment, one of skill understands that the shape of the manifold is not critical.
  • Spout fitting 136 is adapted to removably engage a catheter hub.
  • the tapered region can be a luer taper, or, alternatively, spout fitting 136 can be threaded on an interior wall 136a for engagement of a luer lock catheter.
  • the interior of the catheter hub forms mixing chamber 116 when the catheter is connected to manifold outlet end 110b.
  • FIG. 2B Another embodiment of device 100 wherein manifold 110 is designed for removably connecting delivery spout 124 is illustrated in FIG. 2B.
  • manifold outlet end 110b is a tapered region that forms mixing chamber 116. Fluid channel outlets 112b, 114b terminate at and are continuous with mixing chamber inlet end 116a.
  • Wall 125 of mixing chamber 116 is adapted to removably engage a catheter hub.
  • wall 125 forms a luer taper.
  • a spray jet-type nozzle or other fluid application system can be used in place of a catheter.
  • engagement of a catheter or other fluid application system to the manifold forms the delivery spout.
  • fluid channel outlets 112b, 114b communicate with mixing chamber 116 so that fluid streams ejected from fluid channel outlets 112b, 114b enter mixing chamber 116.
  • the fluid streams mix in mixing chamber 116 and exit catheter 128 through catheter outlet 128b.
  • FIGs. 3 and 4 illustrate the locations of fluid channels 112, 114 and fluid channel outlets 112b, 114b relative to mixing chamber 116 in one embodiment.
  • fluid channels 112, 114 do not intersect, but rather cross over one another in different planes.
  • a center line through fluid channel 112 intersects a wall portion 125a of mixing chamber 116 at an angle ⁇ .
  • Another wall portion 125b of mixing chamber 116 is substantially opposite wall portion 125a, and a center line through fluid channel 114 intersects wall portion 125b at an angle ⁇ .
  • Angles ⁇ and ⁇ can be the same or different, and are illustrated in FIG. 3 as substantially the same angle.
  • FIG. 4 is a transverse section through manifold outlet end 110b showing the location of fluid channel outlets 112b, 114b in the embodiment pictured in FIG. 3.
  • the arrangement of fluid channels 112, 114 and fluid channel outlets 112b, 114b relative to mixing chamber wall portions 125a and 125b described in FIGs. 3 and 4 ensures that fluid streams exiting fluid channel outlets 112b and 114b are not parallel in a common plane.
  • Angles , ⁇ are selected so that fluid streams exiting fluid channel outlets 112b, 114b contact wall portions 125a, 125b, respectively, at a sufficient angle to provide vigorous, swirling mixing.
  • angles , ⁇ are selected so that fluid streams exiting fluid channel outlets 112b, 114b contact wall portions 125a, 125b, respectively, so as to provide sufficient mixing of the fluids prior to ejection of the fluid mixture from mixing chamber 116.
  • angles ⁇ , ⁇ are selected so that the fluid streams contact wall portions 125a, 125b at a distance from manifold outlet end 110 that is one-third or less the length "L" of mixing chamber 116 (FIG. 3) .
  • Those skilled in the art are able to determine suitable angles , ⁇ , depending on fluid viscosity, fluid flow rate, and the size and shape of mixing chamber 116.
  • the chamber can be tapered or contain grooves or ridges to enhance mixing.
  • the shape of the manifold is not critical so long as the manifold is a sufficient length to support fluid channels 112 and 114 at angles ⁇ and ⁇ and that the inlet end of the channels is spaced to facilitate one-handed operation and attachment of two syringes of suitable sizes.
  • the portions of the device of this invention that contact fluid in operation should be inert to the fluid contacted.
  • the fluid delivery systems can include syringes made of a plastic such as polycarbonates, polyurethane, acrylics, ABS polymers, polysolfone, and the like.
  • the inlet fittings, manifold, and nozzle can be made of a similar material.
  • the device is made by conventional methods such as injection molding using wires or pins to provide the channels.
  • the application device and method of the present invention are particularly useful for dispensing fluid mixtures wherein the mixing of a plurality of fluids results in an increase in viscosity sufficient to impair mixture flow.
  • the operation of the application device of the present invention is exemplified herein by the use of the device to prepare and dispense a coagulum-based wound sealant, e.g. a fibrin glue.
  • a coagulum-based wound sealant e.g. a fibrin glue.
  • wound sealants are prepared by mixing a procoagulant-containing solution (which contains fibrinogen) with a solution comprising a fibrinogen activator.
  • Any procoagulant-containing solution useful in preparing prior art wound sealants can be used with the application device, as exemplified herein by a fibrinogen-containing solution.
  • fibrinogen-containing solution containing fibrinogen, other procoagulant proteins, and cellular components of whole blood such as platelets, white cells, and buffy coat can be included in fibrinogen-containing solution.
  • Suitable fibrinogen- containing solutions are typically obtained from plasma separated from anticoagulated whole blood by density difference fractionation (e.g., by gravity or centrifugation) .
  • the fibrinogen content of such solutions is between about 2 mg/ml to about 50 mg/ml.
  • Fibrinogen activators are well known and include thrombin and batroxobin, both of which are commercially available.
  • bovine thrombin is available from a variety of sources including Armour and Parke- Davis.
  • the rate of coagulum formation after mixing fibrinogen with fibrinogen activator is directly dependent on the final concentration of fibrinogen activator in the mixture.
  • the final concentration ranges from about 10 to 100 Units/ml.
  • a coagulum forms in about three to five seconds; at 50 Units/ml, coagulum formation occurs in about 15-
  • a variety of additional components can be added to the fibrinogen or fibrinogen activator solutions to modify the characteristics of the coagulum.
  • Antifibrinolytics can be employed to regulate the time required for the body to break down the coagulum.
  • Platelets can be included in the fibrinogen solution to increase coagulum strength and adhesion, augment hemostasis, and improve healing.
  • calcium can be added to the fibrinogen activator solution to accelerate fibrin crosslinking and stability.
  • Ground bone, demineralized bone matrix, hydroxyapatite, or the like can be included in the fibrinogen activator solution to promote bone regrowth.
  • pharmacologic agents such as, for example, antibiotics, can also be added to the fibrinogen activator solution.
  • the volume ratios of the two solutions are important in determining the strength and adhesiveness of the wound sealant. Fibrinogen solution to fibrinogen activator solution volume ratios of about 5:1 have been successfully employed. However, the incidence of unsatisfactory results is greater than with higher ratios. Ratios of from about 10:1 to about 12:1 are reliably effective. Ratios higher than 12:1 make thorough mixing of the two solutions more difficult and less reliable.
  • the application device of the present invention facilitates the simultaneous delivery of different amounts of the two solutions.
  • the fluid delivery systems include syringes having the same length, but differing cross-sectional areas.
  • gas channel 130 is coupled to a pressurized source of sterile medical gas via flexible tubing connected to gas inlet fitting 132.
  • Medical gas includes any gas suitable for use in a medical procedure, such as air or oxygen. Gas flow can be commenced at any time before, or simultaneously with, the depression of plungers 106, 108. In embodiments where it is not desirable to mix gas with the fluids, gas flow is commenced after cessation of depression of plungers 106, 108.
  • a fibrinogen solution is introduced into syringe 102, which is coupled to fluid channel 112 via fluid inlet fitting 118.
  • a fibrinogen activator solution is introduced into syringe 104, which is coupled to fluid channel 114 via fluid inlet fitting 120.
  • Admixing the fibrinogen solution with gas before mixing with the fibrinogen activator solution prevents sputtering that occurs with currently available devices that mix all three components together at the same point in the device.
  • gas channel outlet 130b is located close to mixing chamber 116, the gas stream exiting gas channel outlet 130b helps prevent the thrombin solution from migrating into fluid channel 112, thereby preventing the formation of a coagulum that could clog fluid channel 112. Fluid channel 114 does not clog because the fibrinogen concentration in the channel is too low.
  • the fibrinogen-gas mixture and the fibrinogen activator solution enter mixing chamber 116 in streams at an angle to each other and at an angle to wall 125 of delivery spout 124, which imparts a swirling motion to the streams, thus promoting the vigorous mixing necessary for a complete reaction between the fibrinogen and thrombin.
  • the mixture is then ejected through catheter 128 under pressure due to a combination of the depression of plungers 106, 108.and gas flow through gas channel 130. After a sufficient amount of the mixture has been applied to a target surface, the pressure on plungers 106, 108 is stopped substantially simultaneously.
  • Sterile medical gas continues to flow along gas channel 130 into the end of fluid channel 112 near fluid channel outlet 112b, thereby purging any residual s fibrinogen solution from the end of fluid channel 112 and any of the coagulating mixture remaining in mixing chamber 116.
  • This feature of the application device ensures that the mixture is cleared from the device before coagulation progresses far enough to clog mixing o chamber 116 or catheter 128. In this manner, device 110 can support intermittent use without requiring cleaning or replacement of parts.
  • one-way valve 134 prevents reflux of the fibrinogen solution along gas channel 130.
  • the present invention also provides a method for preparing and dispensing a mixture of a plurality of o fluids.
  • the method includes admixing a first fluid with a pressurized gas to form a first fluid-gas mixture; vigorously mixing the first fluid-gas mixture with a second fluid in a mixing chamber to form a second fluid-gas mixture; and rapidly dispensing the 5 second fluid-gas mixture through an opening in the mixing chamber.
  • the second fluid-gas mixture may be dispensed by ejecting a stream of the mixture through the opening or by ejecting a spray of the mixture through the opening.
  • the mixing chamber is purged of the second fluid-gas mixture by flowing pressurized gas through the mixing chamber.
  • the dispensing step can 5 optionally be repeated.
  • the mixture to be dispensed is a fibrin glue
  • the first fluid includes fibrinogen
  • the second fluid includes a fibrinogen activator.
  • the pressurized gas is a sterile medical gas.
  • the fibrinogen activator is thrombin.
  • An exemplary wound sealant preparation and application device of this invention was prepared as follows.
  • a manifold similar to that illustrated in FIG. 1 and having a mixing chamber similar to that illustrated in FIG. 2B was made from an acrylic block obtained from TAP Plastics, San Rafael, CA.
  • the dimensions of the plastic formed into a manifold were as follows.
  • the inlet end and the outlet end of the manifold were each about 40 mm in length with the center-to-center distance between the fluid inlet fittings being about 24 mm.
  • the manifold was approximately 58 mm in length and 10 mm in depth.
  • Fluid inlet fittings and the wall forming the mixing chamber were attached to and extended from the manifold.
  • the length of the mixing chamber (measured as illustrated in FIG. 3) was 22 mm.
  • the wall housing the mixing chamber formed a luer taper for attachment of a catheter or other fluid application system.
  • a one-way valve was affixed to a gas inlet fitting grooved into the manifold between the fluid
  • the fluid channels were each about 60 mm in length and 1 mm in diameter.
  • the center-to-center distance between the fluid channel outlets in the top of the mixing chamber was about 2 mm. Therefore, angles ⁇ and ⁇ were each about 12°.
  • the gas channel intersected with the first fluid channel about 8 mm from the outlet of the channel, so that less than 15% of the volume in the fluid channel is ejected by gas exiting the gas channel.
  • the gas and fluid channels were drilled in the manifold using fabricating equipment (Dremel Moto-Tool Model 395-5, Racine, WI) .
  • the one way valve (catalog no. 325452, Vernay Labs, Yellow Springs, OH) was affixed to the gas channel to allow gas to flow through the gas channel toward the junction with the first fluid channel.
  • a catheter tip (2.1 mm x 83 mm Angiocath, catalog no. 38-2832, Deseret Medical Inc., Beckton Dickenson & Co., Sandy, UT) with a luer taper was connected to the wall housing the mixing chamber to form the delivery spout.
  • Syringes (Monoject syringes: MJ12 12 cc syringe, catalog no. 325452 and MJtb 1 cc tuberculin syringe, catalog no. 309626, both from Sherwood Medical, St. Louis, MO) were used as the fluid delivery assemblies.
  • a 1 cc tuberculin syringe from Beckton Dickenson & Co., Sandy, UT (catalog no. 309626) was used.
  • a spray nozzle (Sprayco, Detroit, MI) was used in place of the catheter as the delivery spout.
  • EXAMPLE 2 Preparation of an Alternate Embodiment of the Device of Example 1
  • An alternate embodiment of the Device of Example 1 was prepared as follows. Using fabricating equipment (Dremel Moto-Tool Model 395-5, Racine, WI) , a hole (1 mm in diameter) was drilled in a manifold similar to that illustrated in FIGs. 1 and 2A (DUOFLO manifold, Hemaedics, Pacific Palisades, CA) to form a gas channel that connected with a first fluid channel about 10 mm from the outlet end of the first fluid channel.
  • a one way valve (catalog no. 325452, Vernay Labs, Yellow Springs, OH) was affixed to the third channel to allow gas to flow through the third channel toward the junction with the first fluid channel.
  • a catheter tip (2.1 mm x 83 mm Angiocath, catalog no. 38-2832, Deseret Medical Inc., Beckton Dickenson & Co., Sandy, UT) with a luer taper was attached to form the delivery spout. Syringes were used as the fluid delivery assemblies as described in Example 1.
  • EXAMPLE 3 Preparation of a Wound Sealant
  • a fibrin glue wound sealant was prepared as follows, using the device of Example 2 having the catheter as the delivery spout.
  • the gas channel was connected to a medical air container having a gas line fitted with a 0.2 ⁇ filter.
  • the 12 cc syringe was filled with fibrinogen solution (bovine plasma concentrated using a hemoconcentration ultrafiltration unit (Minntech Corp., Minneapolis, MN) to provide a fibrinogen concentration of 3.5 mg/ml) and the 1 cc syringe was filled with thrombin solution (THROMBINAR, 1,250 U/ml, Armour Pharmaceuticals, Kankakee, IL) .
  • Both syringe barrels were depressed simultaneously and fibrin glue was ejected from the delivery spout.
  • the glue formed a coagulum within about 5 seconds of ejection.
  • Table 1 illustrates the ratio of the cross- sectional areas of the syringe barrels used. TABLE 1
  • tuberculin syringe provided suitable relative volumes of fibrinogen solution and thrombin solution to form a fibrin glue from a thrombin solution and a fibrinogen solution having the concentration used in this example.
  • Table 2 illustrates the starting and diluted values (following mixing) for fibrinogen solution and thrombin solution.
  • the fibrinogen solution (bovine plasma) was diluted with physiologic saline to form the various starting fibrinogen concentrations.
  • the thrombin solution was diluted with water.
  • the first three coagula formed were firm.
  • the third coagulum was soft, and the last was runny and did not set.
  • the 12 cc and tuberculin syringes the first three coagula were very firm, the third was firm and the last formed a soft coagulum.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Mechanical Engineering (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgical Instruments (AREA)
  • Materials For Medical Uses (AREA)
  • Nozzles (AREA)
  • Manufacture Of Motors, Generators (AREA)
  • Application Of Or Painting With Fluid Materials (AREA)

Abstract

La présente invention porte sur un dispositif de préparation et d'application utile pour mélanger et appliquer plusieurs fluides qui doivent être mélangés immédiatement avec l'utilisation. Dans une forme d'exécution, le dispositif comprend deux applicateurs de fluide reliés à un système de deux conduites à fluide séparées. Chaque conduite à fluide débouche dans une chambre de mélange où les fluides sont mélangés et d'où le mélange obtenu est évacué. Le système de conduites à fluide comprend en outre une conduite à gaz qui a une sortie reliée à une des conduites à fluide et qui peut être utilisée pour alimenter la chambre de mélange en gaz sous pression, afin d'en expulser le mélange, ce qui diminue les risques que le mélange ne bouche le dispositif. L'invention porte également sur un procédé de préparation et d'application du mélange de deux fluides.
EP96931360A 1995-06-06 1996-06-05 Dispositif et procede pour preparer et appliquer une composition pour proteger les blessures Ceased EP0957772A2 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US47294195A 1995-06-06 1995-06-06
US472941 1995-06-06
PCT/US1996/008291 WO1996039212A2 (fr) 1995-06-06 1996-06-05 Dispositif et procede pour preparer et appliquer une composition pour proteger les blessures

Publications (1)

Publication Number Publication Date
EP0957772A2 true EP0957772A2 (fr) 1999-11-24

Family

ID=23877518

Family Applications (1)

Application Number Title Priority Date Filing Date
EP96931360A Ceased EP0957772A2 (fr) 1995-06-06 1996-06-05 Dispositif et procede pour preparer et appliquer une composition pour proteger les blessures

Country Status (6)

Country Link
US (1) US5887755A (fr)
EP (1) EP0957772A2 (fr)
JP (1) JPH11506649A (fr)
AU (1) AU708165B2 (fr)
CA (1) CA2222426A1 (fr)
WO (1) WO1996039212A2 (fr)

Families Citing this family (114)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69629010T2 (de) * 1995-01-16 2004-04-15 Baxter International Inc., Deerfield Selbsttragende flächengebilde aus vernetztem fibrin zur hemmung von postoperativen adhäsionen
WO2000062828A1 (fr) * 1996-04-30 2000-10-26 Medtronic, Inc. Fibrine autologue d'obturation et ses methodes de fabrication
DE29723807U1 (de) * 1996-04-30 1999-11-04 Medtronic, Inc., Minneapolis, Minn. Autologe Fibrin-Blutstillungsmittel
EP0917444A1 (fr) * 1996-07-12 1999-05-26 Baxter Travenol Laboratories, Inc. Dispositif distributeur de fibrine et procede de formation de fibrine sur une surface
CA2583144C (fr) * 1996-11-15 2009-03-10 Bristol Myers Squibb Company Dispositifs et procedes utilises pour appliquer un melange de deux composants liquides ou davantage pour former un biomateriau
US6613020B1 (en) 1996-12-06 2003-09-02 Bristol-Myers Squibb Company Method of applying a mixture of two liquid components as well as a device for carrying out the method
US6733472B1 (en) 1997-04-14 2004-05-11 Baxter International Inc. Sealant applicator tip and application method
ATE371472T1 (de) * 1998-03-06 2007-09-15 Baxter Int Turbulenz-mischkopf für gewebeklebstoff- applikator und sprühkopf für selbigen
US6047861A (en) * 1998-04-15 2000-04-11 Vir Engineering, Inc. Two component fluid dispenser
US6461361B1 (en) * 1998-05-01 2002-10-08 Baxter International Inc. Gas-driven spraying of mixed sealant agents
ATE367181T1 (de) 1998-05-21 2007-08-15 Baxter Int Dichtungsmittelapplikator sowie verfahren zum säubern mittels impulsen
US6358236B1 (en) * 1998-08-06 2002-03-19 Baxter International Inc. Device for reconstituting medicaments for injection
ATE502670T1 (de) * 1998-08-14 2011-04-15 Incept Llc Apparat für die in-situ-bildung von hydrogelen
US6179862B1 (en) 1998-08-14 2001-01-30 Incept Llc Methods and apparatus for in situ formation of hydrogels
US7347850B2 (en) 1998-08-14 2008-03-25 Incept Llc Adhesion barriers applicable by minimally invasive surgery and methods of use thereof
ATE380561T1 (de) * 1998-08-18 2007-12-15 Baxter Int Auftragsspitze für ein dichtmittel und auftrageverfahren
ID26845A (id) * 1999-04-06 2001-02-15 Fishman Corp Alat penyalur zat alir elektronik
KR100349797B1 (ko) 1999-09-13 2002-08-22 주)녹십자 피브린 실란트 송출 장치
US6496802B1 (en) 2000-01-07 2002-12-17 Mp3.Com, Inc. System and method for providing access to electronic works
US20030209612A1 (en) * 2000-07-17 2003-11-13 Kevin Hahnen Spray head for applying a multi-component mixture
US20020165483A1 (en) * 2000-11-10 2002-11-07 Curtis Miller Gas assisted spray applicator
SE0100091D0 (sv) * 2001-01-12 2001-01-12 Pharmacia Ab A device and a method for dispensing at least two mutually reactive components
US20040086453A1 (en) * 2001-01-22 2004-05-06 Howes Randolph M. Compositions, methods, apparatuses, and systems for singlet oxygen delivery
US6386396B1 (en) * 2001-01-31 2002-05-14 Hewlett-Packard Company Mixing rotary positive displacement pump for micro dispensing
EP2105096A1 (fr) 2001-02-27 2009-09-30 Tyco Healthcare Group Lp Assemblage de mélangeur extérieur
GB2374014A (en) * 2001-04-02 2002-10-09 Cambridge Consultants Biological sealant storage and dispensing system
US6663596B2 (en) 2001-08-13 2003-12-16 Scimed Life Systems, Inc. Delivering material to a patient
US6921381B2 (en) 2001-10-05 2005-07-26 Baxter International Inc. Laparoscopic spray device and method of use
US6935534B2 (en) * 2002-01-28 2005-08-30 Hewlett-Packard Development Company, L.P. Mixing rotary positive displacement pump for micro dispensing
US20040106896A1 (en) * 2002-11-29 2004-06-03 The Regents Of The University Of California System and method for forming a non-ablative cardiac conduction block
US7901939B2 (en) 2002-05-09 2011-03-08 University Of Chicago Method for performing crystallization and reactions in pressure-driven fluid plugs
ATE479899T1 (de) 2002-05-09 2010-09-15 Univ Chicago Einrichtugn und verfahren für druckgesteuerten plug-transport und reaktion
US6936033B2 (en) * 2002-06-14 2005-08-30 Medtronic, Inc. Multiple ratio fluid dispenser
US7077339B2 (en) 2003-02-03 2006-07-18 Biomet, Inc. Spray applicator
GB0307403D0 (en) 2003-03-31 2003-05-07 Medical Res Council Selection by compartmentalised screening
GB0307428D0 (en) 2003-03-31 2003-05-07 Medical Res Council Compartmentalised combinatorial chemistry
US20060078893A1 (en) 2004-10-12 2006-04-13 Medical Research Council Compartmentalised combinatorial chemistry by microfluidic control
WO2005030034A2 (fr) * 2003-09-26 2005-04-07 Depuy Spine, Inc. Dispositif destine a administrer une matiere visqueuse
US6884232B1 (en) 2003-10-31 2005-04-26 Baxter International Inc. Laparoscopic spray device and method of use
US20070131795A1 (en) * 2003-11-07 2007-06-14 Abbate Anthony J Device and method for mixing and dispensing fluid components of a multicomponent composition
US7229420B2 (en) * 2003-12-23 2007-06-12 Cytyc Corporation Medical instrument for accessing a breast duct for performing a medical procedure
US20050221339A1 (en) 2004-03-31 2005-10-06 Medical Research Council Harvard University Compartmentalised screening by microfluidic control
CN104174071A (zh) 2004-04-28 2014-12-03 安希奥设备国际有限责任公司 用于形成交联生物材料的组合物和***及关联的制备方法与用途
US7610943B2 (en) * 2004-06-10 2009-11-03 Emerald Biosystems, Inc. Systems and methods for dispensing portions of viscous material
US7655470B2 (en) * 2004-10-29 2010-02-02 University Of Chicago Method for manipulating a plurality of plugs and performing reactions therein in microfluidic systems
US9477233B2 (en) * 2004-07-02 2016-10-25 The University Of Chicago Microfluidic system with a plurality of sequential T-junctions for performing reactions in microdroplets
US7718167B2 (en) * 2004-09-13 2010-05-18 Hynes Richard A Method for treating wounds exposing the dura using PPP and PRP
US7490738B2 (en) * 2004-10-01 2009-02-17 Angiotech Pharmaceuticals (Us), Inc. Mixing and dispensing fluid components of a multicomponent composition
US7968287B2 (en) 2004-10-08 2011-06-28 Medical Research Council Harvard University In vitro evolution in microfluidic systems
US7537174B2 (en) 2005-01-12 2009-05-26 Baxter International Inc. Hand triggered tissue sealant spray apparatus and system
US7611494B2 (en) 2005-02-08 2009-11-03 Confluent Surgical, Inc. Spray for fluent materials
US7766900B2 (en) 2005-02-21 2010-08-03 Biomet Manufacturing Corp. Method and apparatus for application of a fluid
US7635343B2 (en) * 2005-04-21 2009-12-22 Arteriocyte Medical Systems, Inc. Fluid dispenser
US8197545B2 (en) 2005-10-27 2012-06-12 Depuy Spine, Inc. Nucleus augmentation delivery device and technique
US20100137163A1 (en) 2006-01-11 2010-06-03 Link Darren R Microfluidic Devices and Methods of Use in The Formation and Control of Nanoreactors
US20090038701A1 (en) 2006-01-17 2009-02-12 Baxter International Inc. Device, system and method for mixing
ES2348940T3 (es) 2006-01-17 2010-12-17 Baxter International Inc. Dispositivo, sistema y método de mezcla.
CN101410049A (zh) * 2006-01-31 2009-04-15 芝加哥大学 用于检验凝血的方法和设备
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
JP2010506136A (ja) 2006-05-11 2010-02-25 レインダンス テクノロジーズ， インコーポレイテッド 微小流体デバイス
US9012390B2 (en) 2006-08-07 2015-04-21 Raindance Technologies, Inc. Fluorocarbon emulsion stabilizing surfactants
US8772046B2 (en) 2007-02-06 2014-07-08 Brandeis University Manipulation of fluids and reactions in microfluidic systems
US8592221B2 (en) 2007-04-19 2013-11-26 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
JP5147465B2 (ja) * 2007-11-08 2013-02-20 テルモ株式会社 塗布具
JP5222591B2 (ja) * 2008-03-12 2013-06-26 テルモ株式会社 塗布具
US8753670B2 (en) * 2008-03-26 2014-06-17 Baxter International Inc. Fibrin foam and process
US8512740B2 (en) 2008-03-26 2013-08-20 Baxter International Inc. Fibrin foam and process for making
US8518272B2 (en) 2008-04-04 2013-08-27 Biomet Biologics, Llc Sterile blood separating system
US12038438B2 (en) 2008-07-18 2024-07-16 Bio-Rad Laboratories, Inc. Enzyme quantification
EP2315629B1 (fr) 2008-07-18 2021-12-15 Bio-Rad Laboratories, Inc. Bibliothèque de gouttelettes
US8210453B2 (en) * 2008-09-12 2012-07-03 Confluent Surgical, Inc. Spray applicator
JP5255386B2 (ja) * 2008-09-24 2013-08-07 テルモ株式会社 塗布具
EP2198949A1 (fr) * 2008-12-18 2010-06-23 Sika Technology AG Outil de distribution pour substances à plusieurs composants
EP2411148B1 (fr) 2009-03-23 2018-02-21 Raindance Technologies, Inc. Manipulation de gouttelettes microfluidiques
US8376989B2 (en) * 2009-03-30 2013-02-19 Covidien Lp Compartmented syringe
EP2475308A1 (fr) 2009-09-08 2012-07-18 Baxter International Inc Système de reconstitution et d'application de produit de fermeture de plaie
US10520500B2 (en) 2009-10-09 2019-12-31 Abdeslam El Harrak Labelled silica-based nanomaterial with enhanced properties and uses thereof
US10837883B2 (en) 2009-12-23 2020-11-17 Bio-Rad Laboratories, Inc. Microfluidic systems and methods for reducing the exchange of molecules between droplets
US8641661B2 (en) 2010-01-05 2014-02-04 Baxter International Inc. Mixing system, kit and mixer adapter
MX2012008845A (es) 2010-01-28 2012-09-28 Omrix Biopharmaceuticals Ltd Metodo para sellado de fibrina mejorado.
US9399797B2 (en) 2010-02-12 2016-07-26 Raindance Technologies, Inc. Digital analyte analysis
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
EP3392349A1 (fr) 2010-02-12 2018-10-24 Raindance Technologies, Inc. Analyse numérique d'analytes
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
ES2962612T3 (es) * 2010-04-05 2024-03-20 Neomend Inc Dispositivo para suministrar composiciones de hidrogel con autopurgado para prevenir obstrucciones
WO2011127045A2 (fr) * 2010-04-05 2011-10-13 Neomend, Inc. Méthode et appareil d'application d'un agent de scellement des plaies
EP3447155A1 (fr) 2010-09-30 2019-02-27 Raindance Technologies, Inc. Dosages en sandwich dans des gouttelettes
EP3412778A1 (fr) 2011-02-11 2018-12-12 Raindance Technologies, Inc. Procédés permettant de former des gouttelettes mélangées
EP2675819B1 (fr) 2011-02-18 2020-04-08 Bio-Rad Laboratories, Inc. Compositions et méthodes de marquage moléculaire
US8841071B2 (en) 2011-06-02 2014-09-23 Raindance Technologies, Inc. Sample multiplexing
EP3216872B1 (fr) 2011-06-02 2020-04-01 Bio-Rad Laboratories, Inc. Quantification d'enzyme
US8658430B2 (en) 2011-07-20 2014-02-25 Raindance Technologies, Inc. Manipulating droplet size
US8586324B2 (en) 2011-08-15 2013-11-19 Biomet Biologics, Llc Method and apparatus to create autologous clotting serum
JP2013202201A (ja) * 2012-03-28 2013-10-07 Terumo Corp 医療用長尺体
US9242846B2 (en) 2012-04-13 2016-01-26 Rooftop Research, Llc Vee manifold
US9499390B1 (en) * 2012-07-17 2016-11-22 Global Agricultural Technology And Engineering, Llc Liquid delivery system
US9381005B2 (en) 2012-10-26 2016-07-05 Baxter International Inc. Spray head for two component mixer
JP6095693B2 (ja) * 2013-01-10 2017-03-15 テルモ株式会社 塗布具
WO2014160083A1 (fr) 2013-03-13 2014-10-02 Applied Cardiovascular Solutions, Llc. Procédés, compositions et dispositifs pour l'occlusion de cavités et de passages
US20140276567A1 (en) * 2013-03-15 2014-09-18 John Goodman Device and System for Dispensing a Biological Sealant
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US9944977B2 (en) 2013-12-12 2018-04-17 Raindance Technologies, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
US11193176B2 (en) 2013-12-31 2021-12-07 Bio-Rad Laboratories, Inc. Method for detecting and quantifying latent retroviral RNA species
US10952709B2 (en) 2014-04-04 2021-03-23 Hyperbranch Medical Technology, Inc. Extended tip spray applicator for two-component surgical sealant, and methods of use thereof
JP6672182B2 (ja) * 2014-06-10 2020-03-25 エシコン エルエルシーＥｔｈｉｃｏｎ ＬＬＣ ステープル留めされた組織を封止するための方法及び装置
US20150351753A1 (en) * 2014-06-10 2015-12-10 Ethicon Endo-Surgery, Inc. Methods and Devices for Reinforcing a Staple Line
US9820791B2 (en) * 2014-08-22 2017-11-21 Kyphon SÀRL Methods of filling bone using bone cement mixing and delivery devices
US10647981B1 (en) 2015-09-08 2020-05-12 Bio-Rad Laboratories, Inc. Nucleic acid library generation methods and compositions
IL261190A (en) 2018-08-16 2019-01-31 Omrix Biopharmaceuticals Ltd Stable liquid preparations of thrombin
US11352247B2 (en) 2018-08-24 2022-06-07 Rooftop Research, Llc Manifold and fluid dispensing systems
KR20220157438A (ko) * 2020-03-24 2022-11-29 보스톤 싸이엔티픽 싸이메드 인코포레이티드 약제 전달 시스템 및 그 사용 방법
CN111632779B (zh) * 2020-05-21 2023-03-24 国网宁夏电力有限公司检修公司 一种用于高压隔离开关的导电液喷涂装置
US20220313948A1 (en) * 2021-03-31 2022-10-06 Ethicon, Inc. Systems, devices and methods for dispensing flowable hemostats that incorporate safety mechanisms for preventing air embolisms
WO2023129802A1 (fr) 2021-12-30 2023-07-06 Baxter International Inc. Solutions de fibrinogène et de thrombine pour colle de fibrine et kit de colle de fibrine

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE426856A (fr) * 1937-04-14
US3179107A (en) * 1962-11-21 1965-04-20 Becton Dickinson Co Hypodermic unit with an improved mounting for a replaceable needle assembly
US3595467A (en) * 1968-01-23 1971-07-27 Luigi Goglio Flexible sealed container provided with a one-way safety valve
US3556348A (en) * 1968-05-20 1971-01-19 Robert J Bristow Fluid mixing and dispensing apparatus
US4040420A (en) * 1976-04-22 1977-08-09 General Dynamics Packaging and dispensing kit
US4109653A (en) * 1977-02-22 1978-08-29 George Kozam Successive delivery multiple barrel syringe
US4083474A (en) * 1977-03-21 1978-04-11 Weyerhaeuser Company Applicator gun for multi-component resin systems
AT366916B (de) * 1980-04-02 1982-05-25 Immuno Ag Vorrichtung zur applikation eines gewebeklebstoffes auf basis von menschlichen oder tierischenproteinen
DE3401089A1 (de) * 1984-01-13 1985-07-18 Hilti Ag, Schaan Setzverfahren fuer befestigungselemente
JPS60129941U (ja) * 1984-02-09 1985-08-31 テルモ株式会社 医療用器具
AT379311B (de) * 1984-03-29 1985-12-27 Immuno Ag Vorrichtung zur applikation eines gewebeklebstoffes
AT382783B (de) * 1985-06-20 1987-04-10 Immuno Ag Vorrichtung zur applikation eines gewebeklebstoffes
DE3523143C2 (de) * 1985-06-28 1998-02-05 Schwing Gmbh F Vorrichtung zum pneumatischen Ausbringen eines hydromechanisch im Dichtstrom geförderten, erhärtenden Baustoffes, insbesondere eines hydraulischen Spritzbetons oder -mörtels
US4743229A (en) * 1986-09-29 1988-05-10 Collagen Corporation Collagen/mineral mixing device and method
US4842581A (en) * 1987-09-11 1989-06-27 Davis Richard C Medical lavage apparatus
US4978336A (en) * 1987-09-29 1990-12-18 Hemaedics, Inc. Biological syringe system
ES2029752T3 (es) * 1988-07-13 1992-09-01 Gurit-Essex Ag Procedimiento para la expulsion de una sustancia contenida en un cartucho y dispositivo para la realizacion del procedimiento.
US4874368A (en) * 1988-07-25 1989-10-17 Micromedics, Inc. Fibrin glue delivery system
US4902281A (en) * 1988-08-16 1990-02-20 Corus Medical Corporation Fibrinogen dispensing kit
US5116315A (en) * 1989-10-03 1992-05-26 Hemaedics, Inc. Biological syringe system
US4979942A (en) * 1989-10-16 1990-12-25 Johnson & Johnson Medical, Inc. Two component syringe delivery system
US5185001A (en) * 1990-01-18 1993-02-09 The Research Foundation Of State University Of New York Method of preparing autologous plasma fibrin and application apparatus therefor
FR2661097A1 (fr) * 1990-04-23 1991-10-25 Fondation Nale Transfusion San Aiguille d'application d'une colle, notamment chirurgicale, comportant plusieurs composants melanges extemporanement.
US5163584A (en) * 1990-12-18 1992-11-17 Polyfoam Products, Inc. Method and apparatus for mixing and dispensing foam with injected low pressure gas
DE4223356A1 (de) * 1992-07-16 1994-01-20 Octapharma Ag Glarus Vorrichtung zur Applikation von Mehrkomponentenprodukten
US5484107A (en) * 1994-05-13 1996-01-16 The Babcock & Wilcox Company Three-fluid atomizer
US5585007A (en) * 1994-12-07 1996-12-17 Plasmaseal Corporation Plasma concentrate and tissue sealant methods and apparatuses for making concentrated plasma and/or tissue sealant

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9639212A2 *

Also Published As

Publication number Publication date
AU708165B2 (en) 1999-07-29
CA2222426A1 (fr) 1996-12-12
JPH11506649A (ja) 1999-06-15
WO1996039212A3 (fr) 1997-02-06
WO1996039212A2 (fr) 1996-12-12
AU7006296A (en) 1996-12-24
US5887755A (en) 1999-03-30

Similar Documents

Publication Publication Date Title
US5887755A (en) Wound sealant preparation and application device and method
KR100367190B1 (ko) 두성분으로구성된혼합물분무장치
US6328229B1 (en) Low volume mixing spray head for mixing and dispensing of two reactive fluid components
CA2415834C (fr) Tete de pulverisation permettant d'appliquer un melange a plusieurs composants
US5368563A (en) Sprayer assembly for physiologic glue
AU721371B2 (en) Devices and methods for applying a mixture of two or more liquid components to form a biomaterial
US6863660B2 (en) Fibrin applicator pistol
KR100349797B1 (ko) 피브린 실란트 송출 장치
US4978336A (en) Biological syringe system
EP1267726B1 (fr) Distributeur de produit adhesif de scellement tissulaire comprenant une partie distale de liaison souple
US6860870B2 (en) Self-cleaning fluid delivery device for medical applications
JP2000505670A (ja) 組織シーラント適用のための方法及び機器
US20020165483A1 (en) Gas assisted spray applicator
WO1997020585A1 (fr) Procede d'application d'un melange de deux composants liquides
JP3960505B2 (ja) 生体組織接着剤塗布用具
US20240180538A1 (en) Fluid mixing and delivery injector system
US20230321674A1 (en) Handheld gas spray system for mixing and dispensing multicomponent compositions

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19971201

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): DE DK FR GB IT SE

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

17Q First examination report despatched

Effective date: 20020219

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: INTERPORE ORTHOPAEDICS, INC.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20020702